Literature DB >> 26785936

The Society of Thoracic Surgeons Composite Score for Rating Program Performance for Lobectomy for Lung Cancer.

Benjamin D Kozower1, Sean M O'Brien2, Andrzej S Kosinski2, Mitchell J Magee3, Rachel Dokholyan2, Jeffery P Jacobs4, David M Shahian5, Cameron D Wright5, Felix G Fernandez6.   

Abstract

BACKGROUND: The Society of Thoracic Surgeons (STS) has developed multidimensional composite quality measures for common cardiac surgery procedures. This first composite measure for general thoracic surgery evaluates STS participant performance for lobectomy in lung cancer patients.
METHODS: The STS lobectomy composite score is composed of two outcomes: risk-adjusted mortality; and any-or-none, risk-adjusted major complications. General Thoracic Surgery Database data were included from 2011 to 2014 to provide adequate sample size, and 95% Bayesian credible intervals were used to determine "star ratings." The STS participants were also compared with national benchmarks (including non-STS participants) using the National Inpatient Sample. Comparisons of discharge mortality, postoperative length of stay, and percent of stage I lung cancers resected using minimally invasive approaches are not included in star ratings but will be reported to participants in STS feedback reports.
RESULTS: The study population included 20,657 lobectomy patients from 231 participating centers. Operative mortality was 1.5%, major complication rate was 9.6%, and median postoperative length of stay was 4 days. Risk-adjusted mortality and major complication rates varied threefold from highest performing (three-star) to lowest performing (one-star) programs. Approximately 5% of participants were one-star, 7% were three-star, and 88% were two-star programs.
CONCLUSIONS: The STS has developed the first general thoracic surgery quality composite measure to compare programs performing lobectomy for lung cancer. This measure will be used for quality assessment and provider feedback, and will be made available for voluntary public reporting.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26785936     DOI: 10.1016/j.athoracsur.2015.10.081

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

Review 1.  Blazing new trails: initial efforts to create a joint Society of Thoracic Surgeons-European Society of Thoracic Surgeons (STS-ESTS) dataset.

Authors:  Christopher W Seder
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  An adaptation of the Hungarian model: the Brazilian model.

Authors:  Maria Teresa Ruiz Tsukazan; Ricardo Mingarini Terra; Benoit Jacques Bibas; Michele Salati
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  A perspective on the Society of Thoracic Surgeons Composite Score for evaluating esophagectomy for esophageal cancer.

Authors:  Shuyin Liang; James D Luketich; Inderpal S Sarkaria
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.

Authors:  Yusef A Syed; William Stokes; Manali Rupji; Yuan Liu; Onkar Khullar; Nikhil Sebastian; Kristin Higgins; Jeffrey D Bradley; Walter J Curran; Suresh Ramalingam; James Taylor; Manu Sancheti; Felix Fernandez; Drew Moghanaki
Journal:  Chest       Date:  2021-11-14       Impact factor: 9.410

5.  Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term Outcomes.

Authors:  Jennie K Choe; Amy Zhu; Alexander J Byun; Junting Zheng; Kay See Tan; Joe Dycoco; Manjit S Bains; Matthew J Bott; Robert J Downey; James Huang; James M Isbell; Daniela Molena; Valerie W Rusch; Bernard J Park; Gaetano Rocco; Smita Sihag; David R Jones; Prasad S Adusumilli
Journal:  JTO Clin Res Rep       Date:  2022-06-18

6.  Lung resection surgery in Jehovah's Witness patients: a 20-year single-center experience.

Authors:  Andy Chao Hsuan Lee; Mark K Ferguson; Jessica Scott Donington
Journal:  J Cardiothorac Surg       Date:  2022-10-20       Impact factor: 1.522

7.  The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer Resection.

Authors:  Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Li-Shiun Chen; Nina Smock; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  Chest       Date:  2021-12-14       Impact factor: 10.262

8.  Assessment of Duration of Smoking Cessation Prior to Surgical Treatment of Non-small Cell Lung Cancer.

Authors:  Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Li-Shiun Chen; Nina Smock; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  Ann Surg       Date:  2021-11-18       Impact factor: 13.787

Review 9.  Patient-Reported Outcomes in Cardiothoracic Surgery.

Authors:  Melanie Subramanian; Benjamin D Kozower; Lisa M Brown; Onkar V Khullar; Felix G Fernandez
Journal:  Ann Thorac Surg       Date:  2019-01       Impact factor: 4.330

10.  Is an activity volume threshold really realistic for lung cancer resection?

Authors:  Alain Bernard; Jonathan Cottenet; Anne-Sophie Mariet; Catherine Quantin; Pierre-Benoit Pagès
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.